These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 33612712)

  • 1. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia.
    Almontasheri A; Al-Husayni F; Alsuraihi AK; Binyahib H; Albanna AS
    Am J Case Rep; 2021 Feb; 22():e929447. PubMed ID: 33612712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
    Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
    Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients.
    Raphael A; Shamriz O; Tvito A; Magen S; Goldberg S; Megged O; Lev A; Simon AJ; Tal Y; Somech R; Eisenberg R; Toker O
    Front Immunol; 2023; 14():1156823. PubMed ID: 37063907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.
    Raman RS; Bhagwan Barge V; Anil Kumar D; Dandu H; Rakesh Kartha R; Bafna V; Aravinda VT; Raghuram TC
    J Infect Dis; 2021 May; 223(9):1538-1543. PubMed ID: 33585890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
    Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
    J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.
    Devassikutty FM; Jain A; Edavazhippurath A; Joseph MC; Peedikayil MMT; Scaria V; Sandhya P; Govindaraj GM
    Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):115-118. PubMed ID: 34495748
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 presenting as severe, persistent abdominal pain and causing late respiratory compromise in a 33-year-old man.
    Walpole SC; McHugh R; Samuel J; Schmid ML
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32546557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe neutropenia in Japanese patients with x-linked agammaglobulinemia.
    Kanegane H; Taneichi H; Nomura K; Futatani T; Miyawaki T
    J Clin Immunol; 2005 Sep; 25(5):491-5. PubMed ID: 16160918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
    Pereira NMD; Heath PT; Doerholt K; Almario-Hernandez AF; Gilmour C; Drysdale SB
    Pediatr Infect Dis J; 2021 Dec; 40(12):e472-e474. PubMed ID: 34596628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19.
    Shi H; Zhou C; He P; Huang S; Duan Y; Wang X; Lin K; Zhou C; Zhang X; Zha Y
    Int J Antimicrob Agents; 2020 Aug; 56(2):105974. PubMed ID: 32298745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
    Li YW; Chen H; Zhang Y; An YF; Tang XM; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):495-500. PubMed ID: 34102824
    [No Abstract]   [Full Text] [Related]  

  • 13. Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin.
    Endo LM; Giannobile JV; Dobbs AK; Foote JB; Szymanska E; Warnock DG; Cook WJ; Conley ME; Schroeder HW
    J Investig Allergol Clin Immunol; 2011; 21(5):405-9. PubMed ID: 21905506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.
    Rawat A; Jindal AK; Suri D; Vignesh P; Gupta A; Saikia B; Minz RW; Banday AZ; Tyagi R; Arora K; Joshi V; Mondal S; Shandilya JK; Sharma M; Desai M; Taur P; Pandrowala A; Gowri V; Sawant-Desai S; Gupta M; Dalvi AD; Madkaikar M; Aggarwal A; Raj R; Uppuluri R; Bhattad S; Jayaram A; Lashkari HP; Rajasekhar L; Munirathnam D; Kalra M; Shukla A; Saka R; Sharma R; Garg R; Imai K; Nonoyama S; Ohara O; Lee PP; Chan KW; Lau YL; Singh S
    Front Immunol; 2020; 11():612323. PubMed ID: 33584693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.
    Manganotti P; Pesavento V; Buoite Stella A; Bonzi L; Campagnolo E; Bellavita G; Fabris B; Luzzati R
    J Neurovirol; 2020 Aug; 26(4):605-606. PubMed ID: 32529516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton's agammaglobulinemia.
    Rise N; Touborg T; Lundsted DH; Dalager-Pedersen M; Mogensen TH
    Front Immunol; 2022; 13():1057065. PubMed ID: 36505407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report.
    Shawkat A; Merrell ET; Fadel GA; Amzuta I; Amin H; Shah AJ; Habeb H; Aiash H
    Am J Case Rep; 2020 Jul; 21():e925786. PubMed ID: 32694498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-Linked Agammaglobulinaemia: Outcomes in the modern era.
    Shillitoe B; Gennery A
    Clin Immunol; 2017 Oct; 183():54-62. PubMed ID: 28729230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous immunoglobulin replacement therapy in X-linked agammaglobulinemia].
    Kanegane H; Nomura K; Futatani T; Miyawaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):337-43. PubMed ID: 16583740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.